tyrosyl-glycyl-glycine has been researched along with Delayed Hypersensitivity in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gottlieb, AA; Gottlieb, MS; Kern, CH; Sizemore, RC | 2 |
| Cone, LA; Fiala, M; Sayre, JW | 1 |
| Fudenberg, HH; Tsang, KY | 1 |
| Gottlieb, AA; Gottlieb, MS; Scholes, VE | 1 |
2 review(s) available for tyrosyl-glycyl-glycine and Delayed Hypersensitivity
| Article | Year |
|---|---|
Transfer factor and other T cell products.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antigens, Neoplasm; Cell Extracts; Cricetinae; Cytotoxicity, Immunologic; Fibrosarcoma; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Interleukin-2; Kidney Neoplasms; Lymphocytes; Lymphokines; Melanoma; Osteosarcoma; Rabbits; RNA; Transfer Factor | 1986 |
Reconstitution of immune function in AIDS/ARC.
Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; AIDS-Related Complex; Humans; Hypersensitivity, Delayed; Immunotherapy; Lymphokines; T-Lymphocytes, Helper-Inducer | 1987 |
3 trial(s) available for tyrosyl-glycyl-glycine and Delayed Hypersensitivity
| Article | Year |
|---|---|
A novel methodology for quantitating the enhancement of cutaneous delayed-type hypersensitivity by IMREG-1: a measure of the immunopotentiation of cell-mediated immunity.
Topics: Adjuvants, Immunologic; Amino Acid Sequence; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunologic Factors; Immunologic Techniques; Lymphokines; Molecular Sequence Data; Peptides; Skin | 1995 |
Rationale and clinical results of using leucocyte-derived immunosupportive therapies in HIV disease.
Topics: Adjuvants, Immunologic; Antiviral Agents; Binding Sites; CD4-Positive T-Lymphocytes; Double-Blind Method; HIV Infections; Humans; Hypersensitivity, Delayed; Immunologic Factors; Leukocytes, Mononuclear; Lymphokines; Placebos; Tetanus Toxoid | 1996 |
Clinical benefits and recovery of delayed-type hypersensitivity in patients with AIDS-related complex treated with IMREG-1 or placebo.
Topics: Adult; AIDS-Related Complex; Double-Blind Method; Humans; Hypersensitivity, Delayed; Immunotherapy; Lymphokines; Male; Opportunistic Infections; Pneumonia, Pneumocystis; Sarcoma, Kaposi | 1991 |